TR200000576T1 - Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem - Google Patents

Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem

Info

Publication number
TR200000576T1
TR200000576T1 TR2000/00576T TR200000576T TR200000576T1 TR 200000576 T1 TR200000576 T1 TR 200000576T1 TR 2000/00576 T TR2000/00576 T TR 2000/00576T TR 200000576 T TR200000576 T TR 200000576T TR 200000576 T1 TR200000576 T1 TR 200000576T1
Authority
TR
Turkey
Prior art keywords
liposomal encapsulated
applying
taxane
encapsulated taxane
liposomal
Prior art date
Application number
TR2000/00576T
Other languages
English (en)
Turkish (tr)
Inventor
Rahman Aquilar
Original Assignee
Neopharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharm filed Critical Neopharm
Publication of TR200000576T1 publication Critical patent/TR200000576T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR2000/00576T 1998-07-01 1999-06-29 Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem TR200000576T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/108,509 US6146659A (en) 1998-07-01 1998-07-01 Method of administering liposomal encapsulated taxane

Publications (1)

Publication Number Publication Date
TR200000576T1 true TR200000576T1 (tr) 2000-11-21

Family

ID=22322617

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00576T TR200000576T1 (tr) 1998-07-01 1999-06-29 Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem

Country Status (17)

Country Link
US (1) US6146659A (fr)
EP (1) EP1009384A4 (fr)
JP (2) JP2001524990A (fr)
KR (1) KR20010023522A (fr)
CN (1) CN1275076A (fr)
AU (1) AU730599B2 (fr)
BR (1) BR9906581A (fr)
CA (1) CA2301057C (fr)
EA (1) EA003678B1 (fr)
HU (1) HUP0004583A3 (fr)
IL (1) IL134747A0 (fr)
NO (1) NO20001012L (fr)
NZ (1) NZ524490A (fr)
PL (1) PL338951A1 (fr)
SK (1) SK4642000A3 (fr)
TR (1) TR200000576T1 (fr)
WO (1) WO2000001366A1 (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087954A1 (en) * 1997-01-07 2003-05-08 Sonus Pharmaceuticals, Inc. Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7112338B2 (en) * 1997-03-12 2006-09-26 The Regents Of The University Of California Cationic liposome delivery of taxanes to angiogenic blood vessels
US7262173B2 (en) * 1997-03-21 2007-08-28 Georgetown University Chemosensitizing with liposomes containing oligonucleotides
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6461637B1 (en) * 2000-09-01 2002-10-08 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US7314637B1 (en) * 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
US20040006242A1 (en) * 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
US6835721B2 (en) * 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
US6815173B1 (en) * 1999-06-09 2004-11-09 The United States Of America As Represented By The Department Of Health And Human Services Method for detecting syphilis using synthetic antigents
HUP0202669A3 (en) * 1999-09-09 2004-06-28 Univ California Cationic liposome delivery of taxanes to angiogenic bloos vessels
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
ES2272496T3 (es) * 2000-02-04 2007-05-01 Lipoxen Technologies Limited Procedimiento de deshidratacion/rehidritacion para la preparacion de lipososmas.
US20030133972A1 (en) * 2000-10-11 2003-07-17 Targesome, Inc. Targeted multivalent macromolecules
US20030129223A1 (en) * 2000-10-11 2003-07-10 Targesome, Inc. Targeted multivalent macromolecules
IL155696A0 (en) 2000-11-09 2003-11-23 Neopharm Inc Sn-38 lipid complexes and methods of use
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
WO2003030864A1 (fr) * 2001-05-29 2003-04-17 Neopharm, Inc. Formulation liposomale d'irinotecan
CA2354486A1 (fr) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. Taxanes substitues avec un ester en c7
WO2003018018A2 (fr) * 2001-08-24 2003-03-06 Neopharm, Inc. Compositions de vinorelbine et methodes d'utilisation
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
WO2003039600A1 (fr) * 2001-11-09 2003-05-15 Neopharm, Inc. Traitement selectif des tumeurs exprimant l'interleukine 13
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
NZ536308A (en) 2002-05-24 2009-01-31 Angiotech Int Ag Compositions and methods for coating medical implants
WO2003102011A1 (fr) * 2002-05-29 2003-12-11 Neopharm, Inc. Procede de determination de la concentration en oligonucleotides
CA2491312C (fr) * 2002-07-15 2011-05-31 Alcon, Inc. Film bioeroable pour l'administration de medicaments ophtalmiques
KR100533458B1 (ko) 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
WO2004017944A1 (fr) * 2002-08-23 2004-03-04 Neopharm, Inc. Compositions de gemcitabine pour une administration de medicaments amelioree
WO2004069224A2 (fr) * 2003-02-03 2004-08-19 Neopharm, Inc. Taxane liposomal encapsule, stable, sterile et filtrable et autres medicament antineoplasiques
MXPA05008489A (es) * 2003-02-11 2005-10-18 Neopharm Inc Procedimiento de fabricacion para preparaciones liposomicas.
WO2004087758A2 (fr) * 2003-03-26 2004-10-14 Neopharm, Inc. Anticorps du recepteur alpha 2 il 13 et procedes d'utilisation
EP1643971A2 (fr) * 2003-05-22 2006-04-12 Neopharm, Inc. Formulations liposomales combinees
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
EP2286794B8 (fr) 2003-10-15 2016-06-01 SynCore Biotechnology CO., LTD Utilisation de liposomes cationiques avec paclitaxel
WO2005087222A1 (fr) 2004-03-05 2005-09-22 Florida State University Research Foundation, Inc. Taxanes a substitution de c7 lactyloxy-
EP1744764B1 (fr) * 2004-04-22 2012-05-30 Celator Pharmaceuticals, Inc. Formulations a vecteur intracellulaires pour anthracycliniques et analogues cytidiniques
JP4433918B2 (ja) * 2004-07-15 2010-03-17 コニカミノルタエムジー株式会社 画像形成方法
JP2008518925A (ja) * 2004-10-29 2008-06-05 ネオファーム、インコーポレイティッド リポソーム製剤の製造プロセス
EP1827395A2 (fr) 2004-11-02 2007-09-05 Tel-Aviv University Future Technology Development L.P. Formulations de medicaments insolubles dans l'eau ou faiblement solubles dans l'eau dans des particules de glycosaminoglycane lipides et leur utilisation dans des diagnostics et une therapie
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
WO2006116423A2 (fr) 2005-04-26 2006-11-02 Eisai Co., Ltd Compositions et procedes destines a l'immunotherapie du cancer
EP1896007B1 (fr) 2005-05-04 2014-03-19 Medigene AG Methode d'administration d'une preparation liposomale cationique contenant du paclitaxel
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.
KR20080110681A (ko) 2006-04-20 2008-12-18 암겐 인코포레이티드 안정적 에멀젼 조제물
WO2008058156A2 (fr) 2006-11-06 2008-05-15 Jina Pharmaceuticals Inc. Procédés et compositions autour de guggulphospholipides
GB0905348D0 (en) 2009-03-27 2009-05-13 Ucl Business Plc Carrier
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
EP2480208A1 (fr) 2009-09-23 2012-08-01 Indu Javeri Méthodes de préparation de liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
PL226015B1 (pl) * 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
CA2894846A1 (fr) 2012-12-12 2014-06-19 Temple University - Of The Commonwealth System Of Higher Education Compositions et methodes de traitement du cancer
WO2014165829A2 (fr) * 2013-04-05 2014-10-09 Igdrasol Formulations de nanoparticules
EP3043781A1 (fr) 2013-09-13 2016-07-20 Arbor Therapeutics, LLC Compositions de nanoparticules pour l'administration ciblée de médicaments lipophiles et de promédicaments lipophiles labiles en milieu acide d'agents chimiothérapeutiques anti-cancéreux, et leur préparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
DK0706373T3 (da) * 1992-03-23 2000-09-18 Univ Georgetown Liposomindkapslet taxol og en fremgangsmåde til anvendelse heraf
WO1994026254A1 (fr) * 1993-05-17 1994-11-24 The Liposome Company, Inc. Incorporation de taxol dans des liposomes et des gels
JPH06329533A (ja) * 1993-05-20 1994-11-29 Kyowa Hakko Kogyo Co Ltd リポソーム製剤の製造法
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE4430593C2 (de) * 1994-08-20 1999-01-14 Max Delbrueck Centrum Verfahren zur Herstellung von Liposomal verkapseltem Taxol
WO1996015774A1 (fr) * 1994-11-18 1996-05-30 Aphios Corporation Procedes et dispositifs de confection de liposome contenant des medicaments hydrophobes
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
JP4192208B2 (ja) * 1995-09-12 2008-12-10 セファロン リミテッド 加水分解促進性のタキサン疎水性誘導体
CA2189916C (fr) * 1996-11-08 2001-01-16 Parkash S. Gill Un nouveau regime pour l'administration de paclitaxel a des malades souffrant du sarcoma de kaposi

Also Published As

Publication number Publication date
AU730599B2 (en) 2001-03-08
EP1009384A4 (fr) 2004-11-17
WO2000001366A1 (fr) 2000-01-13
AU5088099A (en) 2000-01-24
JP2001524990A (ja) 2001-12-04
EA003678B1 (ru) 2003-08-28
HUP0004583A3 (en) 2002-04-29
EP1009384A1 (fr) 2000-06-21
NO20001012D0 (no) 2000-02-29
US6146659A (en) 2000-11-14
NO20001012L (no) 2000-03-15
SK4642000A3 (en) 2000-11-07
CA2301057A1 (fr) 2000-01-13
BR9906581A (pt) 2000-09-26
EA200000282A1 (ru) 2000-10-30
IL134747A0 (en) 2001-04-30
KR20010023522A (ko) 2001-03-26
JP2004059590A (ja) 2004-02-26
PL338951A1 (en) 2000-12-04
CA2301057C (fr) 2009-03-10
NZ524490A (en) 2005-04-29
CN1275076A (zh) 2000-11-29
HUP0004583A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
DE60115842D1 (de) Ventilanordnung
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
WO2004006842A3 (fr) Association de medicaments pour le traitement de tumeurs
ATE329903T1 (de) Hochgradig lipophile camptothecin-derivate
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
BR0213424A (pt) Uso aperfeiçoado de composto antitumoral na terapia contra câncer
WO2004006849A3 (fr) Combinaisons de medicaments pour le traitement de neoplasmes
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
MY135460A (en) Method of stimulating hair growth using benzopyrans
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
NO20014812D0 (no) Fremgangsmåte for tilveiebringelse av kosmetisk/medisinsk terapi
ATE233745T1 (de) Arzneistoffe
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
BR0114856A (pt) Combinação compreendendo camptotecina e um derivado de estilbeno para o tratamento de câncer
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
IT1304342B1 (it) Composizione per il trattamento cosmetico topico della cellulite.
UA38148A (uk) Спосіб комплексного лікування коловидного облисіння
DE60030593D1 (de) Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien
GR1004988B (el) Λιποσωμιακο σκευασμα που περιεχει φωσφολιπιδιο, λιπιδιο και λαβδανικου τυπου διτερπενιο